SANA has garnered increasing attention in metabolic research for offering a distinct approach to studying energy expenditure and thermogenesis. Rather than focusing primarily on appetite regulation, researchers are investigating it for its ability to influence creatine-dependent energy expenditure in adipose tissue. For pharmaceutical companies, metabolic research laboratories, and institutions evaluating emerging small-molecule drugs, understanding its chemical properties, mechanism of action, and research applications matters far more than viewing it merely as a weight-management product.
What is SANA
SANA powder is a synthetic small-molecule compound with a structure derived from a salicylic acid backbone. Its full chemical name is 2-hydroxy-5-(2-nitrovinyl)benzoic acid; 5-(2-nitrovinyl)salicylic acid is another commonly used name. PubChem records list the CAS number as 42571-07-3, the molecular formula as C₉H₇NO₅, and the molecular weight as 209.16 g/mol.
Structurally, the compound possesses several key chemical features: an aromatic salicylic acid ring, a phenolic hydroxyl group, a carboxylic acid group, and a conjugated nitro-olefin substituent. The nitro-olefin moiety is particularly significant, as it imparts unique chemical and biological properties that distinguish the compound from conventional salicylate compounds. This distinction is crucial when utilizing the compound as a research material. Although the molecule is structurally based on salicylate, published studies indicate that its metabolic activity cannot be explained as an extension of the pharmacological effects of traditional salicylates. Instead, researchers have investigated SANA as a unique small molecule that can influence energy metabolism in adipose tissue.
For research institutions requiring the compound, chemical properties and analytical quality are paramount. Reliable research-grade materials should include appropriate documentation, such as CAS information, molecular formula, molecular weight, purity assays, and structural identification data. Depending on the specific project, techniques such as High-Performance Liquid Chromatography (HPLC), Liquid Chromatography-Mass Spectrometry (LC-MS), and Nuclear Magnetic Resonance (NMR) spectroscopy may be employed to verify composition and assess batch quality.
What is the mechanism of action of SANA
Its most notable characteristic is its impact on creatine-dependent thermogenesis.
No single pathway governs energy expenditure in adipose tissue. Classic thermogenesis is closely linked to uncoupling protein 1 (UCP1) in brown adipose tissue. However, researchers have identified an energy-consuming process involving creatine metabolism, sometimes called the futile creatine cycle.
Current research indicates that SANA increases energy expenditure and stimulates non-shivering thermogenesis in adipose tissue. Importantly, this effect has been reported to occur independently of UCP1 and AMPK activation. The thermogenic response is significantly reduced upon creatine depletion, suggesting that creatine metabolism plays a pivotal role. The study also provided further mechanistic evidence using mice lacking the Ckmt1 gene (which encodes mitochondrial creatine kinase). These mice showed an impaired response to the compound, further supporting a link between the compound's activity and creatine-dependent energy-expenditure pathways.
Another significant finding is that its mechanism of action does not appear to rely solely on direct mitochondrial uncoupling. Instead, researchers observed enhanced mitochondrial respiration in adipocytes in vivo, accompanied by changes associated with creatine-dependent thermogenesis. This gives the compound considerable scientific significance, as it offers researchers a tool to explore alternative pathways for increasing energy expenditure.
Thus, the sequence is: SANA → adipose tissue metabolic signaling → increased creatine-dependent energy expenditure → enhanced thermogenesis → increased energy expenditure. However, the precise molecular target that initiates this pathway remains a key area requiring further investigation. This distinction is crucial for pharmaceutical companies: The compound should currently be regarded as a mechanistic research tool.
What are the benefits and applications of SANA
SANA's potential benefits are primarily linked to metabolism and drug development, rather than existing consumer-facing applications.
In animal models of diet-induced obesity, published studies indicate that it promotes weight loss, improves glucose handling, reduces insulin resistance, and prevents metabolic abnormalities, including hepatic steatosis. Notably, in relevant mouse experiments, these effects occurred without a significant reduction in cumulative food intake, suggesting that increased energy expenditure-rather than mere appetite suppression-plays a key role.
SANA also demonstrates activity under thermoneutral conditions; this is scientifically significant as it allows researchers to investigate whether adipose thermogenesis can influence metabolism independently of cold stimulation. Researchers have reported that, under these experimental conditions, the compound prevents diet-induced obesity and improves glucose-related parameters.
Early human studies have also heightened interest in the compound. A Phase 1A/B study evaluated single doses of 200–800 mg in healthy volunteers, as well as multiple daily doses of 200–400 mg over 15 days in overweight or obese individuals. While the primary objective was to assess safety and tolerability, exploratory evaluations included pharmacokinetics, body weight, and metabolic markers. Results showed a favorable short-term safety and tolerability profile, alongside preliminary changes in body weight and glucose-related parameters.
Consequently, for research institutions and drug development teams, potential applications include: studies on adipose tissue thermogenesis; research into creatine metabolism and energy expenditure; investigations into obesity and metabolic diseases; studies on mitochondrial respiration and glucose/insulin resistance; structure-activity relationship (SAR) research; and preclinical evaluation of novel metabolic pathways.
The compound's value extends beyond its status as an emerging metabolic compound. Its greater research value lies in providing a distinct chemical tool for exploring creatine-dependent thermogenesis and other mechanisms of energy expenditure. In laboratory or pharmaceutical research, SANA offers a compelling case study of how modifying a familiar chemical scaffold can yield a compound with distinct biological properties. While existing evidence supports continued investigation, further clinical studies are required before concluding its long-term efficacy, safety, or therapeutic use in humans.
For more information about SANA powder, please contact Xi'an Sonwu.
Email: sales@sonwu.com
References：https://pubchem.ncbi.nlm.nih.gov/compound/2-Hydroxy-5-_2-nitroethenyl_benzoic-acid?